US2016320379A1PendingUtilityA1

Magnetic-nanoparticle conjugates and methods of use

Assignee: MASSACHUSETTS GEN HOSPITALPriority: Jun 6, 2001Filed: Dec 1, 2015Published: Nov 3, 2016
Est. expiryJun 6, 2021(expired)· nominal 20-yr term from priority
G01N 33/5434Y10S435/969Y10S977/773G01N 33/54346A61K 49/1851B82Y 5/00C07H 21/02C12Q 1/44Y10T436/143333C07K 1/22C07F 15/02Y10S977/918C12Q 1/37Y10S977/92C12Q 1/6816G01N 33/54326G01N 33/577
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides novel compositions of binding moiety-nanoparticle conjugates, aggregates of these conjugates, and novel methods of using these conjugates, and aggregates. The nanoparticles in these conjugates can be magnetic metal oxides, either monodisperse or polydisperse. Binding moieties can be, e.g., oligonucleotides, polypeptides, or polysaccharides. Oligonucleotide sequences are linked to either non-polymer surface functionalized metal oxides or with functionalized polymers associated with the metal oxides. The novel compositions can be used in assays for detecting target molecules, such as nucleic acids and proteins, in vitro or as magnetic resonance (MR) contrast agents to detect target molecules in living organisms.

Claims

exact text as granted — not AI-modified
1 - 73 . (canceled) 
     
     
         74 . A method for purifying a target molecule from a sample, the method comprising
 obtaining a conjugate comprising a nanoparticle comprising a magnetic metal oxide linked by a cleavable bond to a binding moiety that specifically binds to a binding site on the target molecule;   obtaining a sample containing the target molecule in a fluid;   mixing the conjugates with the sample under conditions sufficient to enable target molecules in the sample to bind to the binding moiety on the conjugate to form target molecule-binding moiety complexes;   separating the conjugates from the sample; and   cleaving the cleavable bond to separate the target molecule-binding moiety complexes from the conjugates, thereby purifying the target molecules.   
     
     
         75 . The method of  claim 74 , wherein the target molecule is a nucleic acid, and the binding moiety is an oligonucleotide that is complementary to a portion of the target nucleic acid. 
     
     
         76 . The method of  claim 74 , wherein the target molecule is a polypeptide, and the binding moiety is an antibody that specifically binds to a portion of the target polypeptide. 
     
     
         77 - 82 . (canceled)

Join the waitlist — get patent alerts

Track US2016320379A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.